-
C498450-500mgClindamycin.
-
-
C651804-10mgCratoxylone, isolated from the bark of Cratoxylum Cochinchinense , possesses antiplasmodial activity.
-
C651804-1mgCratoxylone, isolated from the bark of Cratoxylum Cochinchinense , possesses antiplasmodial activity.
-
C651804-5mgCratoxylone, isolated from the bark of Cratoxylum Cochinchinense , possesses antiplasmodial activity.
-
-
-
D412165-100mgInformationDDD107498 DDD107498 (M-5717, DDD-498) is a P. falciparum translation elongation factor 2 inhibitor. DDD107498 exhibits a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite.
-
D412165-10mgInformationDDD107498 DDD107498 (M-5717, DDD-498) is a P. falciparum translation elongation factor 2 inhibitor. DDD107498 exhibits a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite.
-
D412165-25mgInformationDDD107498 DDD107498 (M-5717, DDD-498) is a P. falciparum translation elongation factor 2 inhibitor. DDD107498 exhibits a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite.
-
D412165-50mgInformationDDD107498 DDD107498 (M-5717, DDD-498) is a P. falciparum translation elongation factor 2 inhibitor. DDD107498 exhibits a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite.
-
D412165-5mgInformationDDD107498 DDD107498 (M-5717, DDD-498) is a P. falciparum translation elongation factor 2 inhibitor. DDD107498 exhibits a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite.